It is prescribed for individuals with a body mass index (BMI) of 30 or greater or those with a BMI between 27 and 30 who have weight-related health conditions, such as high blood pressure or type 2 diabetes Ozempic (Semaglutide) , while effective for weight loss in some clinical trials, is approved in Singapore for diabetes management, not as a dedicated weight loss treatment
The Phase 2 clinical trial showed roughly 2-3 kg more fat loss than placebo over 12 weeks, with no impact on blood sugar, insulin, IGF-1, or any hormonal marker
Because semaglutide slows how quickly food and drugs move through the stomach, the absorption timing of pills you take by mouth can shift
Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, Ali S, Kim M, Kabir MG, Seino Y, Suzuki J, Drucker DJ (2018) Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction